Daniel Crozet
Analyst
Guggenheim
Equibles does not estimate personal net worth.
About Daniel Crozet
Daniel Crozet is recorded as Analyst at Guggenheim. Daniel Crozet has spoken on 1 investor event across 1 company, most recently for Rein Therapeutics, Inc. on November 9, 2026. The companies whose calls Daniel Crozet spoke on are classified in the Healthcare sector.
Daniel Crozet on recent calls
“So as you touched upon, United Therapeutics, Tyveso, you know, it did show that inhaled therapy can lead to benefit in these patients. So I guess what are your key takeaways from what we saw in that program, and how do you think your drugs sort of differentiates from Tyveso?”
Affiliation history
-
Guggenheim
Analyst
Transcript header (unverified)
Current